Shell Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,259
Closed -$224K 1413
2022
Q2
$224K Buy
14,259
+25
+0.2% +$382 0.01% 1089
2022
Q1
$216K Sell
14,234
-2,154
-13% -$32.8K 0.01% 1149
2021
Q4
$252K Buy
16,388
+28
+0.2% +$368 0.01% 1145
2021
Q3
$142K Sell
16,360
-750
-4% -$6.84K ﹤0.01% 1260
2021
Q2
$175K Buy
+17,110
New +$181K ﹤0.01% 1261
2017
Q3
Sell
-62,211
Closed -$480K 1122
2017
Q2
$480K Hold
62,211
0.01% 917
2017
Q1
$561K Sell
62,211
-4,354
-7% -$45.4K 0.01% 853
2016
Q4
$720K Sell
66,565
-582
-0.9% -$7.76K 0.02% 773
2016
Q3
$1.1M Buy
+67,147
New +$945K 0.02% 616

Other funds holding NPTN

Shell Asset Management's NPTN Position: Q3 2022 in Review

Shell Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 14,259 shares — an estimated $224K sold.

Shell Asset Management first reported a position in NPTN in Q3 2016 and held it in 9 quarters. The position peaked at $1.1M in Q3 2016. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Shell Asset Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Shell Asset Management sold 14,259 NEOPHOTONICS CORP shares in Q3 2022, an estimated $224K.
  • Shell Asset Management first reported a position in NEOPHOTONICS CORP in Q3 2016 and held it in 9 quarters.
  • Shell Asset Management's NEOPHOTONICS CORP position peaked at $1.1M in Q3 2016.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Shell Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.